- Cogent Biosciences (NASDAQ:COGT) announced on Wednesday it has secured a debt financing facility of up to $400 million with credit funds managed by SLR Capital Partners.
- Under the terms of the agreement, Cogent drew $50 million from the facility at closing. An additional $100
Cogent bBosciences secures up to $400 million in non-dilutive financing
Recommended For You
More Trending News
About COGT Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| COGT | - | - |
| Cogent Biosciences, Inc. | ||